Myriad Genetics Inc. (MYGN): Today's Featured Diversified Services Laggard

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Myriad Genetics ( MYGN) pushed the Diversified Services industry lower today making it today's featured Diversified Services laggard. The industry as a whole closed the day up 0.7%. By the end of trading, Myriad Genetics fell $1.97 (-6.8%) to $26.85 on average volume. Throughout the day, 2,739,577 shares of Myriad Genetics exchanged hands as compared to its average daily volume of 2,249,900 shares. The stock ranged in price between $26.66-$28.96 after having opened the day at $28.96 as compared to the previous trading day's close of $28.82. Other companies within the Diversified Services industry that declined today were: Pointer Telocation ( PNTR), down 9.0%, CTPartners Executive Search ( CTP), down 7.6%, SmartPros ( SPRO), down 6.4% and Corporate Resource Services ( CRRS), down 6.2%.

Myriad Genetics, Inc., a molecular diagnostic company, focuses on the development and marketing of predictive medicine, personalized medicine, and prognostic medicine tests primarily in the United States. Myriad Genetics has a market cap of $2.2 billion and is part of the services sector. Shares are up 5.8% year to date as of the close of trading on Monday. Currently there are 4 analysts that rate Myriad Genetics a buy, 1 analyst rates it a sell, and 8 rate it a hold.

TheStreet Ratings rates Myriad Genetics as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and attractive valuation levels. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.

On the positive front, Xueda Education Group ( XUE), up 14.0%, China Yida ( CNYD), up 13.4%, Learning Tree International ( LTRE), up 9.0% and Envestnet ( ENV), up 5.9% , were all gainers within the diversified services industry with Visa ( V) being today's featured diversified services industry leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the diversified services industry could consider iShares Dow Jones US Cons Services ( IYC) while those bearish on the diversified services industry could consider ProShares Ultra Short Consumer Sers ( SCC).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Biotech Movers: Jazz Shares Lower Amid Notes Offering

Biotech Movers: Myriad Genetics, Spectrum Pharmaceuticals, Array BioPharma

Bullish and Bearish Reversals in the Market

Biotech Premarket Movers: Sage Therapeutics, Immunomedics, Myriad Genetics

Gilead Sciences Leads Biotech Movers -- Plus Jim Cramer's Comments